Flexion Therapeutics (FLXN) Tops Q3 EPS by 10c
Tweet
Share
E-mailGet Alerts FLXN Hot Sheet
Join SI Premium – FREE
Flexion Therapeutics (NASDAQ: FLXN) reported Q3 EPS of ($0.45), $0.10 better than the analyst estimate of ($0.55).
For earnings history and earnings-related data on Flexion Therapeutics (FLXN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Boston Omaha Corporation (BOC) Misses Q2 EPS by 2c
- KULR Technology Group (KULR) Misses Q2 EPS by 39c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
